Skip to main content

Table 4 Association between HR-HPV infection and Sexual health and Behavior variables

From: High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program

 

HR-HPV n(%)

HR-HPV (by any genotype)

HPV 16 n(%)

HPV 16 infection

HPV 18 n(%)

HPV 18 infection

non-16/18 HR-HPV n(%)

Non-16/18 HR-HPV

Age Adjusted

OR (95% CI)a

Multivariate Adjusted

OR (95% CI)b

Age Adjusted

OR (95% CI)a

Multivariate Adjusted

OR (95% CI)b

Age Adjusted

OR (95% CI)a

Multivariate Adjusted OR (95% CI)b

Age Adjusted

OR (95% CI)a

Multivariate Adjusted

OR (95% CI)b

History of Hormonal Contraception

 No

12,985(13)

1 (ref)

1 (ref)

2149(2.1)

1 (ref)

1 (ref)

960(0.9)

1 (ref)

1 (ref)

11,115(11)

1 (ref)

1 (ref)

 Yes

2055(15)

1.09(1.03–1.148)

1.06(1.008–1.118)

373(2.7)

1.12(0.968–1.299)

1.09(0.940–1.265)

133(0.9)

0.89(0.700–1.152)

0.90(0.704–1.160)

1764(13)

1.08(1.027–1.152)

1.05(1.003–1.119)

Number of lifetime sexual partners

 None

662(12)

1 (ref)

1 (ref)

100(1.8)

1 (ref)

1 (ref)

53(0.9)

1 (ref)

1 (ref)

564(10)

1 (ref)

1 (ref)

 1 to 5

13,606(13)

1.01(0.937–1.108)

1.00(0.925–1.094)

2292(2.1)

1.14(0.878–1.478)

1.12(0.864–1.455)

984(0.9)

0.76(0.544–1.062)

0.76(0.548–1.071)

11,642(11)

1.01(0.925–1.116)

1.00(0.914–1.103)

 6 to 10

637(25)

1.88(1.665–2.127)

1.79(1.590–2.034)

101(3.9)

1.60(1.106–2.329)

1.51(1.041–2.203)

42(1.6)

0.95(0.547–1.668)

0.97(0.557–1.711)

564(22)

1.90(1.665–2.183)

1.82(1.590–2.089)

  > 11

135(22)

1.72(1.395–2.125)

1.65(1.336–2.038)

29(4.7)

2.39(1.403–4.091)

2.27(1.329–3.885)

14(2.2)

1.77(0.820–3.828)

1.80(0.834–3.906)

109(18)

1.50(1.185–1.922)

1.44(1.137–1.845)

Tobacco Use

      

 No

12,813(13)

1 (ref)

1 (ref)

2119(2.1)

1 (ref)

1 (ref)

948(0.9)

1 (ref)

1 (ref)

10,963(11)

1 (ref)

1 (ref)

 Yes

2227(16)

1.21(1.157–1.278)

1.18(1.124–1.243)

403(2.8)

1.24(1.081–1.435)

1.20(1.045–1.392)

145(1)

0.96(0.755–1.222)

0.95(0.748–1.218)

1916(14)

1.21(1.147–1.281)

1.16(1.102–1.233)

  1. HR-HPV n(%): number of cases and HR-HPV prevalence understood as the percentage of women with at least one high-risk HPV genotype detected by specific stratum for each evaluated characteristic
  2. HPV 16 n(%): number of cases and prevalence of single HPV 16 infection without coinfection with other HR-HPV, by specific stratum for each evaluated characteristic
  3. HPV 18 n(%): number of cases and prevalence of single HPV 18 infection without coinfection with other HR-HPV, by specific stratum for each evaluated characteristic
  4. Non-16/18 HR-HPV n(%):number of cases and prevalence of single other HR-HPV non 16 and 18 infection without coinfection with HPV 16 or HPV 18, by specific stratum for each evaluated characteristic
  5. a. Odds ratios for all the variables adjusted by age
  6. b. Odds ratios for all the variables adjusted by age, number of lifetime sexual partners, history of hormonal contraception and tobacco use with the exception of exposition variable itself
  7. Statistically significant p values ≤0.05 of the OR’s are marked in bold font